Showing 1-6 of 6 results for "AB1248"
Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
Edwards, R J, et al.
Biochemical Pharmacology, 49, 39-47 (1995)
P-450 cytochromes: structure and function.
Black, S D and Coon, M J
Advances in Enzymology and Related Areas of Molecular Biology, 60, 35-87 (1987)
Patricia Prieto et al.
Frontiers in physiology, 7, 548-548 (2016-12-03)
Stem cell therapy has emerged as a promising new area in regenerative medicine allowing the recovery of viable tissues. Among the many sources of adult stem cells, bone marrow-derived are easy to expand in culture via plastic adherence and their...
D R Nelson et al.
DNA and cell biology, 12(1), 1-51 (1993-01-01)
We provide here a list of 221 P450 genes and 12 putative pseudogenes that have been characterized as of December 14, 1992. These genes have been described in 31 eukaryotes (including 11 mammalian and 3 plant species) and 11 prokaryotes....
Ting Xu et al.
Medical science monitor : international medical journal of experimental and clinical research, 26, e922149-e922149 (2020-04-15)
BACKGROUND Leonurine is an active component of the traditional Chinese medicine Leonurus japonicus. This study aimed to investigate the effects of overexpressed CYP450s on the metabolic activity of leonurine. MATERIAL AND METHODS BEAS-2B cells stably expressing CYP1A1, 1A2, 2A13, 2B6...
P E Thomas et al.
Federation proceedings, 46(8), 2563-2566 (1987-06-01)
Cytochrome P-450 is the terminal oxidase of an electron transport system that is responsible for the oxidative metabolism of a large variety of endogenous and exogenous compounds. This broad substrate selectivity is caused by multiple isozymes of cytochrome P-450 and...

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.